Drug Type Small molecule drug |
Synonyms (E)-9,10-Dehydroepothilone D, (E)-9,10-Didehydroepothilone D, 9,10-Didehydroepothilone D + [5] |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors, Tubulin polymerisation promoters |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H39NO5S |
InChIKeyXAYAKDZVINDZGB-BMVMHAJPSA-N |
CAS Registry350493-61-7 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| metastatic non-small cell lung cancer | Phase 2 | United States | 01 Apr 2008 |





